These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11278160)

  • 1. Estrogen - a potential treatment for schizophrenia.
    Kulkarni J; Riedel A; de Castella AR; Fitzgerald PB; Rolfe TJ; Taffe J; Burger H
    Schizophr Res; 2001 Mar; 48(1):137-44. PubMed ID: 11278160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of adjunctive oestrogen treatment in women with schizophrenia.
    Kulkarni J; Riedel A; de Castella AR; Fitzgerald PB; Rolfe TJ; Taffe J; Burger H
    Arch Womens Ment Health; 2002 Nov; 5(3):99-104. PubMed ID: 12510212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial.
    Weiser M; Levi L; Zamora D; Biegon A; SanGiovanni JP; Davidson M; Burshtein S; Gonen I; Radu P; Slobozean Pavalache K; Nastas I; Hemi R; Ryan T; Davis JM
    JAMA Psychiatry; 2019 Oct; 76(10):1009-1017. PubMed ID: 31365044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen in severe mental illness: a potential new treatment approach.
    Kulkarni J; de Castella A; Fitzgerald PB; Gurvich CT; Bailey M; Bartholomeusz C; Burger H
    Arch Gen Psychiatry; 2008 Aug; 65(8):955-60. PubMed ID: 18678800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogens and men with schizophrenia: is there a case for adjunctive therapy?
    Kulkarni J; de Castella A; Headey B; Marston N; Sinclair K; Lee S; Gurvich C; Fitzgerald PB; Burger H
    Schizophr Res; 2011 Feb; 125(2-3):278-83. PubMed ID: 21062669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
    Citrome L; Casey DE; Daniel DG; Wozniak P; Kochan LD; Tracy KA
    Psychiatr Serv; 2004 Mar; 55(3):290-4. PubMed ID: 15001730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.
    Khodaie-Ardakani MR; Khosravi M; Zarinfard R; Nejati S; Mohsenian A; Tabrizi M; Akhondzadeh S
    Acta Med Iran; 2015; 53(6):337-45. PubMed ID: 26069170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study.
    Bergemann N; Parzer P; Kaiser D; Maier-Braunleder S; Mundt C; Klier C
    Psychoneuroendocrinology; 2008 May; 33(4):507-16. PubMed ID: 18343039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
    Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-week, randomized, double-blind, placebo-controlled study of the efficacy and safety of risperidone in adolescents with schizophrenia.
    Haas M; Unis AS; Armenteros J; Copenhaver MD; Quiroz JA; Kushner SF
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):611-21. PubMed ID: 20035579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial.
    Ghanizadeh A; Rezaee Z; Dehbozorgi S; Berk M; Akhondzadeh S
    Psychiatry Res; 2014 Nov; 219(3):431-5. PubMed ID: 25017614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.
    Bergemann N; Parzer P; Jaggy S; Auler B; Mundt C; Maier-Braunleder S
    Schizophr Bull; 2008 Nov; 34(6):1172-81. PubMed ID: 18156639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.
    Freudenreich O; Henderson DC; Walsh JP; Culhane MA; Goff DC
    Schizophr Res; 2007 May; 92(1-3):90-4. PubMed ID: 17321111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study.
    Nikbakhat MR; Arabzadeh S; Zeinoddini A; Khalili Z; Rezaei F; Mohammadinejad P; Ghaleiha A; Akhondzadeh S
    Pharmacopsychiatry; 2016 Jul; 49(4):162-9. PubMed ID: 26902281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.
    Canuso CM; Goldstein JM; Wojcik J; Dawson R; Brandman D; Klibanski A; Schildkraut JJ; Green AI
    Psychiatry Res; 2002 Aug; 111(1):11-20. PubMed ID: 12140115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age.
    Kulkarni J; Gavrilidis E; Wang W; Worsley R; Fitzgerald PB; Gurvich C; Van Rheenen T; Berk M; Burger H
    Mol Psychiatry; 2015 Jun; 20(6):695-702. PubMed ID: 24732671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.